Company / SG&A per Share
Doximity SG&A per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.24
FY2024
5-year range
$0.19 / $0.44
FY2020-FY2024
Trend
+19.8%
vs FY2023
Sector context
#147 of 150
Health Care
What the data says
Among 150 Health Care companies, Doximity is in the top 2% for sg&a per share. Improved from $0.44 to $0.24 over the past 2 years.
Based on SEC 10-K filings.
0.24 in FY2024 with a 5-year CAGR of +20.9%.
Improved from $0.44 to $0.24 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +8.0%
- 5-Year CAGR
- +20.9%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 150This company $0.24 Sector average $11878.17
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2024, sg&a per share increased 19.8% year-over-year.
- Ranks #147 out of 150 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2022.
- Lowest sg&a per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.24 | +19.8% |
| FY2023 | $0.20 | -55.6% |
| FY2022 | $0.44 | +136.8% |
| FY2021 | $0.19 | +7.9% |
| FY2020 | $0.17 | +90.3% |
| FY2019 | $0.09 | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026